Pharmacokinetics and Side Effects of the mGlu5 Antagonist Fenobam in Adult Healthy Volunteers
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
This is a randomized, blinded, parallel group, placebo-controlled trial on 32 evaluable
healthy male and non-pregnant female, 18-50 year old volunteers. The investigators goal is to
observe the pharmacokinetics of fenobam after oral administration of 50, 100 or 150 mg in
groups of healthy individuals and to compare the side effects and tolerability of a single
dose of fenobam with placebo.